CMPX logo

Compass Therapeutics (CMPX) Company Overview

Profile

Full Name:

Compass Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 5, 2021

Indexes:

Not included

Description:

CMPX, or Compass Therapeutics, is a biotechnology company focused on developing innovative therapies for cancer and autoimmune diseases. They utilize advanced technologies to create monoclonal antibodies that target specific proteins, aiming to improve patient outcomes and advance treatment options in the medical field.

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 25, 25 D. Boral Capital
Buy
Feb 24, 25 Guggenheim
Buy
Feb 19, 25 Piper Sandler
Overweight
Feb 10, 25 Jefferies
Buy
Jan 10, 25 HC Wainwright & Co.
Buy
Jan 8, 25 HC Wainwright & Co.
Buy
Jan 8, 25 D. Boral Capital
Buy
Dec 23, 24 D. Boral Capital
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Nov 12, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Compass Therapeutics?
  • Does Compass Therapeutics pay dividends?
  • What sector is Compass Therapeutics in?
  • What industry is Compass Therapeutics in?
  • What country is Compass Therapeutics based in?
  • When did Compass Therapeutics go public?
  • Is Compass Therapeutics in the S&P 500?
  • Is Compass Therapeutics in the NASDAQ 100?
  • Is Compass Therapeutics in the Dow Jones?
  • When was Compass Therapeutics's last earnings report?
  • When does Compass Therapeutics report earnings?
  • Should I buy Compass Therapeutics stock now?

What is the ticker symbol for Compass Therapeutics?

The ticker symbol for Compass Therapeutics is NASDAQ:CMPX

Does Compass Therapeutics pay dividends?

No, Compass Therapeutics does not pay dividends

What sector is Compass Therapeutics in?

Compass Therapeutics is in the Healthcare sector

What industry is Compass Therapeutics in?

Compass Therapeutics is in the Biotechnology industry

What country is Compass Therapeutics based in?

Compass Therapeutics is headquartered in United States

When did Compass Therapeutics go public?

Compass Therapeutics's initial public offering (IPO) was on April 5, 2021

Is Compass Therapeutics in the S&P 500?

No, Compass Therapeutics is not included in the S&P 500 index

Is Compass Therapeutics in the NASDAQ 100?

No, Compass Therapeutics is not included in the NASDAQ 100 index

Is Compass Therapeutics in the Dow Jones?

No, Compass Therapeutics is not included in the Dow Jones index

When was Compass Therapeutics's last earnings report?

Compass Therapeutics's most recent earnings report was on Nov 12, 2024

When does Compass Therapeutics report earnings?

The next expected earnings date for Compass Therapeutics is Mar 21, 2025

Should I buy Compass Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions